The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...
President Donald Trump on Thursday said he plans to follow through on Saturday on his threat to impose 25 percent tariffs on goods from Mexico and Canada.